Metraipolis › archive › dc_5ea1f79fbfa0

Platelet-mitochondria dual-targeted nanocarriers for enhanced empagliflozin therapy in atherosclerosis — Europe PMC PMID:40989555

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40989555
DOI: 10.3389/fbioe.2025.1638034
License (as archived): solo-consultazione
Archived: 2026-11-10T01:32:13.403Z
SHA-256 of the archived text: 391f4c8a44c321c530b485dd8ae5a35ea0080df0bee189ad81ba34c0c08997b6
Stable URL of this page: https://metraipolis.com/documento/dc_5ea1f79fbfa0

How to cite

Platelet-mitochondria dual-targeted nanocarriers for enhanced empagliflozin therapy in atherosclerosis — Europe PMC PMID:40989555 — Europe PMC (en), https://europepmc.org/article/MED/40989555 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5ea1f79fbfa0 (Metraipolis archive dc_5ea1f79fbfa0, sha256 391f4c8a44c321c530b485dd8ae5a35ea0080df0bee189ad81ba34c0c08997b6)

BibTeX

@misc{dc5ea1f79fbfa0,
  title = {Platelet-mitochondria dual-targeted nanocarriers for enhanced empagliflozin therapy in atherosclerosis — Europe PMC PMID:40989555},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40989555},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5ea1f79fbfa0; sha256 391f4c8a44c321c530b485dd8ae5a35ea0080df0bee189ad81ba34c0c08997b6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40989555. Agents can read the archived copy with the MCP tool read_document.